Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4216 to 4230 of 7677 results

  1. Anticipatory prescribing:- What is the clinical and cost effectiveness of anticipatory prescribing for patients dying in their usual place of residence, on patient and carer reported symptoms at end of life?

    Recommendation ID NG31/4 Question Anticipatory prescribing:- What is the clinical and cost effectiveness of anticipatory prescribing for

    Research recommendation
    Published
    27 January 2016

  2. Should women having a surgical abortion up to and including 10 +0  weeks' gestation have anti-D prophylaxis if they are RhD (or D) negative?

    Recommendation ID NG140/3 Question Should women having a surgical abortion up to and including 10 +0 weeks' gestation have anti-D prophylaxis

    Research recommendation
    Published
    8 November 2019

  3. Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective treatment for idiopathic pulmonary fibrosis?

    Recommendation ID CG163/5 Question Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective

    Research recommendation
    Published
    9 June 2015

  4. Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically and cost effective in reducing surgical site infection rates?

    Recommendation ID NG125/4 Question Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically

    Research recommendation
    Published
    16 August 2019

  5. What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations in the prevention of surgical site infection when applied to the skin before incision?

    Recommendation ID NG125/3 Question What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations

    Research recommendation
    Published
    16 August 2019

  6. What is the clinical and cost effectiveness of a block and replace regimen compared with a titration regimen of antithyroid drugs for Graves' disease?

    Recommendation ID NG145/8 Question What is the clinical and cost effectiveness of a block and replace regimen compared with a titration

    Research recommendation
    Published
    10 February 2020

  7. What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for people with T3 thyrotoxicosis due to Graves' disease?

    Recommendation ID NG145/6 Question What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for

    Research recommendation
    Published
    10 February 2020

  8. Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid drugs?

    Recommendation ID NG145/3 Question Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid

    Research recommendation
    Published
    10 February 2020

  9. Decision-to-birth interval (category 2 urgency): A prospective study to determine whether the decision-to-birth interval has an impact on maternal and neonatal outcomes when there is a category 2 level of urgency for caesarean birth.

    Recommendation ID NG192/03 Question Decision-to-birth interval (category 2 urgency): A prospective study to determine whether the decision-to-birth

    Research recommendation
    Published
    24 April 2023

  10. Augmentative and alternative communication systems:- Are augmentative and alternative communication systems clinically and cost effective in promoting  communication for adults with cerebral palsy who have communication difficulties?

    Recommendation ID NG119/6 Question Augmentative and alternative communication systems:- Are augmentative and alternative communication

    Research recommendation
    Published
    8 March 2019

  11. Awareness of risk among black, Asian and other minority ethnic groups: Are black, Asian and other minority ethnic groups aware that they are at the same risk of type 2 diabetes and mortality at a lower BMI, compared with the white population?

    Recommendation ID CG189/10 Question Awareness of risk among black, Asian and other minority ethnic groups: Are black, Asian and other minority

    Research recommendation
    Published
    30 September 2022

  12. Children and young people with special educational needs: Are children and young people with special educational needs at higher risk of poor social, emotional and mental wellbeing?

    Recommendation ID NG223/06 Question Children and young people with special educational needs: Are children and young people with special

    Research recommendation
    Published
    4 August 2022

  13. Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are clinicians, practitioners and weight management service providers aware that black, Asian and other minority ethnic groups are at the same risk of type 2 diabetes and mortality at a lower BMI compared with the white population. If so, do they intervene at lower BMI and waist-to-height ratio thresholds?

    Recommendation ID CG189/11 Question Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are

    Research recommendation
    Published
    30 September 2022

  14. Raising awareness about pelvic floor dysfunction: Are community-based strategies effective in raising awareness about the prevention of pelvic floor dysfunction?

    Recommendation ID NG210/16 Question Raising awareness about pelvic floor dysfunction: Are community-based strategies effective in raising

    Research recommendation
    Published
    7 January 2022

  15. Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can tools be developed and/or existing ones further refined and validated to: - assess disease severity and impact in both non-specialist and specialist healthcare settings, to facilitate assessment, appropriate referral, treatment planning and measurement of outcomes - measure burden and cumulative effect of disease activity, severity and impact for people with both psoriasis and psoriatic arthritis?

    Recommendation ID CG153/1 Question Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can

    Research recommendation
    Published
    9 June 2015